MedPath

Glucotrack

🇺🇸United States
Ownership
-
Employees
6
Market Cap
-
Website
Introduction

GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid. It was designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Rutherford, NJ.

Feasibility Study to Evaluate an Intravascular Blood Continuous Glucose Sensor

Not Applicable
Recruiting
Conditions
Diabetes Mellitus
First Posted Date
2025-01-08
Last Posted Date
2025-01-08
Lead Sponsor
Glucotrack
Target Recruit Count
10
Registration Number
NCT06764069
Locations
🇧🇷

Instituto do Coração (InCor) |, São Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath